M Satomi Selected Research

M Satomi Research Topics

2	Neoplasms (Cancer) 04/2004 - 01/2000
2	Diarrhea 02/2001 - 01/2000
1	Crohn Disease (Crohn's Disease) 04/2003
1	Ulcerative Colitis 04/2003
1	Infections 04/2002
1	Colitis 02/2001
1	Fetal Resorption 03/2000
1	Spontaneous Abortion (Miscarriage) 03/2000
1	Asthenia 01/2000
1	Liver Neoplasms (Liver Cancer) 01/2000
1	Nausea 01/2000
1	Parkinson Disease (Parkinson's Disease) 01/2000
1	Alopecia (Baldness) 01/2000
1	Sarcoma (Soft Tissue Sarcoma) 01/2000
1	Vomiting 01/2000
1	Colorectal Neoplasms (Colorectal Cancer) 01/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2000

2	Antineoplastic Agents (Antineoplastics)IBA 04/2004 - 01/2000
1	soblidotin (TZT 1027)IBA 04/2004
1	dolastatin 10IBA 04/2004
1	Peptides (Polypeptides)IBA 04/2003
1	AntibodiesIBA 04/2003
1	Proteins (Proteins, Gene)FDA Link 02/2001
1	Immunoglobulin E (IgE)IBA 02/2001
1	AntigensIBA 02/2001
1	Dextran SulfateIBA 02/2001
1	Dietary Fiber FDA Link 02/2001
1	Monoclonal AntibodiesIBA 03/2000
1	Cell Adhesion MoleculesIBA 03/2000
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 03/2000
1	CytokinesIBA 03/2000
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2000
1	Transaminases (Aminotransferases)IBA 01/2000
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2000
1	AminesIBA 01/2000
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2000
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2000
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2000
1	exatecan (DX 8951f)IBA 01/2000
1	EsterasesIBA 01/2000
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2000
1	CamptothecinIBA 01/2000

1	Intravenous Infusions 04/2004
1	Therapeutics 04/2002